Mergers & Acquisitions
Using synthetic biology and AI to address global antimicrobial resistance threat | MIT News
James J. Collins, the Termeer Professor of Medical Engineering and Science at MIT and faculty co-lead of the Abdul Latif
Tag: synthetic biology
Mergers & Acquisitions
3 Questions: Using AI to accelerate the discovery and design of therapeutic drugs | MIT News
In the pursuit of solutions to complex global challenges including disease, energy demands, and climate change, scientific researchers, including at
Services
AI-Powered Evo-2 Model Generates DNA, Advances Genome Research
Breakthrough in AI-Driven Genome Design A new artificial intelligence model has been introduced, marking a significant advancement in biological research.